Vanda Pharmaceuticals Inc. (VNDA) stock
VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.75−0.06 (-1.57%)
Close on Nov 18, 2026Market cap $226.76MP/E –Yield –
Vanda Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vanda Pharmaceuticals's enterprise value was $195.00M on Nov 11, 2026, against $246.73M a year earlier. Over the last 5 years it ranged from -$22.16M to $567.98M, with a median of $178.79M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $195.00M | -56.8% |
| 2025 | Dec 31, 2025 | $451.20M | +152.4% |
| 2024 | Dec 31, 2024 | $178.79M | +200.0% |
| 2023 | Dec 29, 2023 | $59.59M | -83.8% |
| 2022 | Dec 30, 2022 | $368.79M | -21.2% |
| 2021 | Dec 31, 2021 | $468.10M | +26.5% |
| 2020 | Dec 31, 2020 | $370.07M | -41.9% |
| 2019 | Dec 31, 2019 | $637.41M | -43.5% |
| 2018 | Dec 31, 2018 | $1.13B | +108.2% |
| 2017 | Dec 29, 2017 | $542.11M | -2.9% |
| 2016 | Dec 30, 2016 | $558.11M | +119.5% |
| 2015 | Dec 31, 2015 | $254.30M | -40.8% |
| 2014 | Dec 31, 2014 | $429.37M | +59.2% |
| 2013 | Dec 31, 2013 | $269.72M | – |
| 2012 | Dec 31, 2012 | -$29.97M | – |
| 2011 | Dec 30, 2011 | -$27.64M | -155.0% |
| 2010 | Dec 31, 2010 | $50.27M | – |
See a number that looks wrong?